Watch the Webinar
An Integrative Approach to Modulating Self-Tissue Response in Joints
Presented by: Felice Gersh, MD+
Self-tissue response in joints affects 1 in 200 adults globally, predominantly women.1,2 This condition mainly targets joints, but can also impact other organs, which has the potential to impact quality of life. Early intervention can often make integrative methods the main approach for self-tissue response in joints.
While conventional therapies offer new management possibilities, they are most effective when combined with integrative modalities.
This presentation will cover key manifestations, clinical markers and drivers of self-tissue response, offering integrative strategies to manage the condition while improving quality of life and health span.
Join us to learn how to implement effective integrative approaches for self-tissue response in joints and improve patient outcomes.
Learning Objectives:
- Recognize the key manifestations, contributing factors, and systemic impacts of self-tissue response in joints.
- Discuss conventional therapeutic management of self-tissue response in joints.
- Review a comprehensive, integrative approach for managing self-tissue response in joints to help improve patient outcomes.
About the Speaker
Felice L. Gersh, M.D.+, is an award-winning physician, board-certified in both OB/GYN and Integrative Medicine. She has special expertise in the use of female hormones, the impact of environmental toxicants on metabolic and reproductive functions and on all aspects of lifestyle medicine. She graduated from Princeton University and the University of Southern California School of Medicine. She completed her OB/GYN residency at Kaiser Hospital in Los Angeles and was fellowship-trained in integrative medicine at the University of Arizona School of Medicine. Dr. Gersh is the Medical Director of the Integrative Medical Group of Irvine and helped co-develop the PureWoman™ exclusive.
+Dr. Gersh is a retained advisor for Pure Encapsulations.
1Silman AJ, Pearson JE. Arthritis Res. 2002;4 (Suppl 3):S265-S2722Shah B, American College of Rheumatology Committee on Communications and Marketing. Updated February 2023.
